Skip to content

On this page

Kanuma

sebelipase alfa

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Kanuma

Proper name

sebelipase alfa

Licence type

351(a)

BLA number

125561

Applicant

Alexion Pharmaceuticals, Inc.

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
20MG/10ML (2MG/ML)	Injection	Intravenous	Single-Dose Vial	Rx	December 8, 2015

Exclusivity

Source: Purple Book

Kind	Expires
Orphan exclusivity	December 8, 2022

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity